Medical Developments International | MVP - Le Bénéfice D'Exploitation

Prix De L'Action
0.44
Variation Quotidienne
-0.02 -4.35%
Mensuellement
12.82%
Annuel
-22.81%
Q2 Prévisions
0.51




Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Genetic Signatures AUD -6.34M 1.67M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organon & Co USD 217M 171M 2025-12
Paradigm Biopharmaceuticals AUD -21.57M 13.07M 2025-12
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Starpharma Holdings AUD -873K 1.43M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12